Revealing Progesterone's Role in Uterine and Mammary Gland Biology: Insights from the Mouse

ABSTRACT

Apart from distinguishing the in vivo effects of progesterone (P) from those of estrogen (E), the progesterone receptor knockout (PRKO) mouse has furnished unprecedented access to novel cell-signaling paradigms, hitherto unsuspected. Along with providing new cellular principles by which P influences proliferative and differentiative programs obligate for tissue development and tumor progression, the PRKO in conjunction with transcript profiling has begun to uncover the transcriptional cascades underlying these processes. Moreover, studies on isoform-specific knockouts for PR-A (PR-AKO) and PR-B (PR-BKO) have clearly defined distinct physiological roles for the two subtypes of PR, providing essential physiological support for previous in vitro observations. Although the PR-AKO exhibits an infertility phenotype, the PR-BKO displays normal fecundity. Conversely, although normal mammary morphogenesis can manifest in the PR-AKO, pregnancy-associated mammary morphogenesis is severely impaired in the PR-BKO. By virtue of its ability to suppress E-induced and PR-B-mediated uterine and mammary proliferation, the PR-A isoform is likely to be an attractive drug target for the next generation of selective PR modulators in the treatment of uterine and mammary gland hyperplasia. Along with defining the dynamic interplay between E and P responses and physiological events mediated by PR-A and PR-B, further studies on these models should provide a broader conceptual framework for understanding abnormal progestin responses in vivo, with attendant implications for the management of female reproductive health and for the diagnosis and/or treatment of breast cancer.

KEYWORDS

Progesterone receptor - isoforms - mouse - uterus - mammary gland

REFERENCES

• 1 Allen W M. Physiology of the corpus luteum V.  Am J Physiol. 1930;  92 174-188
• 2 Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins.  J Mol Biol. 1961;  3 318-356
• 3 Jensen E V, Suzuki T, Kawashima T et al.. A two-step mechanism for the interaction of estradiol with rat uterus.  Proc Nat Acad Sci USA. 1969;  59 632-638
• 4 O'Malley B W, McGuire W L, Kohler P O, Korenman S G. Studies on the mechanism of steroid hormone regulation of synthesis of specific proteins.  Recent Prog Horm Res. 1969;  25 105-160
• 5 Tsai M J, O'Malley B W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members.  Annu Rev Biochem. 1994;  63 451-486
• 6 Mangelsdorf D J, Thummel C, Beato M et al.. The nuclear receptor superfamily: the second decade.  Cell. 1995;  83 835-839
• 7 Sartorius C A, Melville M Y, Hovland A R et al.. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform.  Mol Endocrinol. 1994;  8 1347-1360
• 8 Bain D L, Franden M A, McManaman J L, Takimoto G S, Horwitz K B. The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors.  J Biol Chem. 2001;  276 23825-23831
• 9 Tung L, Shen T, Abel M G et al.. Mapping the unique activation function 3 in the progesterone B-receptor upstream segment. Two LXXLL motifs and a tryptophan residue are required for activity.  J Biol Chem. 2001;  276 39843-39851
• 10 Takimoto G S, Tung L, Abdel-Hafiz H et al.. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure.  J Steroid Biochem Mol Biol. 2003;  85 209-219
• 11 Onate S A, Tsai S Y, Tsai M J, O'Malley B W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.  Science. 1995;  270 1354-1357
• 12 Kamei Y, Xu L, Heinzel T et al.. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.  Cell. 1996;  85 403-414
• 13 Giangrande P H, Kimbrel E A, Edwards D P, McDonnell D P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.  Mol Cell Biol. 2000;  20 3102-3115
• 14 Giangrande P H, Pollio G, McDonnell D P. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.  J Biol Chem. 1997;  272 32889-32900
• 15 Hovland A R, Powell R L, Takimoto G S, Tung L, Horwitz K B. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors.  J Biol Chem. 1998;  273 5455-5460
• 16 Schrader W T, O'Malley B W. Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits.  J Biol Chem. 1972;  247 51-59
• 17 Horwitz K B, Alexander P S. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation.  Endocrinology. 1983;  113 2195-2201
• 18 Soyal S M, Ismail P M, Li J, DeMayo F J, Lydon J P. Genomic organization and comparative analysis of the murine progesterone receptor gene. Paper presented at the 84th Meeting of the Endocrine Society June 19-22, 2002 San Francisco, CA;
• 19 Conneely O M, Maxwell B L, Toft D O, Schrader W T, O'Malley B W. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA.  Biochem Biophys Res Commun. 1987;  149 493-501
• 20 Kastner P, Krust A, Turcotte B et al.. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.  EMBO J. 1990;  9 1603-1614
• 21 Tora L, Gronemeyer H, Turcotte B, Gaub M P, Chambon P. The N-terminal region of the chicken progesterone receptor specifies target gene activation.  Nature. 1988;  333 185-188
• 22 Meyer M E, Quirin-Stricker C, Lerouge T, Bocquel M T, Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.  J Biol Chem. 1992;  267 10882-10887
• 23 Vegeto E, Shahbaz M M, Wen D X et al.. Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function.  Mol Endocrinol. 1993;  7 1244-1255
• 24 Sartorius C A, Tung L, Takimoto G S, Horwitz K B. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.  J Biol Chem. 1993;  268 9262-9266
• 25 Mangal R K, Wiehle R D, Poindexter III A N, Weigel N L. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle.  J Steroid Biochem Mol Biol. 1997;  63 195-202
• 26 Mote P A, Johnston J F, Manninen T, Tuohimaa P, Clarke C L. Detection of progesterone receptor forms A and B by immunohistochemical analysis.  J Clin Pathol. 2001;  54 624-630
• 27 Mote P A, Balleine R L, McGowan E M, Clarke C L. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma.  Hum Reprod. 2000;  15(suppl 3) 48-56
• 28 Arnett-Mansfield R L, deFazio A, Wain G V et al.. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.  Cancer Res. 2001;  61 4576-4582
• 29 Ismail P M, Li J, DeMayo F J, O'Malley B W, Lydon J P. A novel lacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development.  Mol Endocrinol. 2002;  16 2475-2489
• 30 Hewitt S C, Korach K S. Estrogen receptors: structure, mechanisms and function.  Rev Endocr Metab Disord. 2002;  3 193-200
• 31 Lydon J P, DeMayo F J, Funk C R et al.. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities.  Genes Dev. 1995;  9 2266-2278
• 32 Lydon J P, DeMayo F J, Conneely O M, O'Malley B W. Reproductive phenotypes of the progesterone receptor null mutant mouse.  J Steroid Biochem Mol Biol. 1996;  56 67-77
• 33 Mani S K, Allen J M, Lydon J P et al.. Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice.  Mol Endocrinol. 1996;  10 1728-1737
• 34 Chappell P E, Lydon J P, Conneely O M, O'Malley B W, Levine J E. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene.  Endocrinology. 1997;  138 4147-4152
• 35 Phelps S M, Lydon J P, O'Malley B W, Crews D. Regulation of male sexual behavior by progesterone receptor, sexual experience, and androgen.  Horm Behav. 1998;  34 294-302
• 36 Chappell P E, Schneider J S, Kim P et al.. Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice.  Endocrinology. 1999;  140 3653-3658
• 37 Lydon J P, Ge G, Kittrell F S, Medina D, O'Malley B W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.  Cancer Res. 1999;  59 4276-4284
• 38 Robker R L, Russell D L, Espey L L et al.. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases.  Proc Natl Acad Sci USA. 2000;  97 4689-4694
• 39 Soyal S, Ismail P M, Li J et al.. Progesterone receptors-animal models and cell signaling in breast cancer: progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics.  Breast Cancer Res. 2002;  4 191-196
• 40 Ismail P M, Amato P, Soyal S M et al.. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor “knockout” and “knockin” mouse models.  Steroids. 2003;  68 779-787
• 41 Eddy E M, Washburn T F, Bunch D O et al.. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility.  Endocrinology. 1996;  137 4796-4805
• 42 Schneider J S, Stone M K, Wynne-Edwards K E et al.. Progesterone receptors mediate male aggression toward infants.  Proc Natl Acad Sci USA. 2003;  100 2951-2956
• 43 Lydon J P, Soyal S, O'Malley B W, Ismail P M. The progesterone receptor knockout mouse model: new insights into progesterone action in vivo. In: Matzuk MM, Brown CW, Kumar TR Contemporary Endocrinology: Transgenics in Endocrinology. Totowa, NJ; Humana Press 2000: 173-204
• 44 Mulac-Jericevic B, Mullinax R A, DeMayo F J, Lydon J P, Conneely O M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform.  Science. 2000;  289 1751-1754
• 45 Conneely O M, Lydon J P. Progesterone receptors in reproduction: functional impact of the A and B isoforms.  Steroids. 2000;  65 571-577
• 46 Mulac-Jericevic B, Lydon J P, DeMayo F J, Conneely O M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform.  Proc Natl Acad Sci USA. 2003;  100 9744-9749
• 47 Conneely O M, Mulac-Jericevic B, Lydon J P. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms.  Steroids. 2003;  68 771-778
• 48 Picard F, Wanatabe M, Schoonjans K et al.. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta-cell proliferation.  Proc Natl Acad Sci USA. 2002;  99 15644-15648
• 49 Tibbetts T A, DeMayo F, Rich S, Conneely O M, O'Malley B W. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility.  Proc Natl Acad Sci USA. 1999;  96 12021-12026
• 50 Vazquez F, Rodriguez-Manzaneque J C, Lydon J P et al.. Progesterone regulates proliferation of endothelial cells.  J Biol Chem. 1999;  274 2185-2192
• 51 Karas R H, van Eickels M, Lydon J P et al.. A complex role for the progesterone receptor in the response to vascular injury.  J Clin Invest. 2001;  108 611-618
• 52 Carson D D, Bagchi I C, Dey S K et al.. Embryo implantation.  Dev Biol. 2000;  223 217-237
• 53 Rinkenberger J L, Cross J C, Werb Z. Molecular genetics of implantation in the mouse.  Dev Genet. 1997;  21 6-20
• 54 Paria B C, Lim H, Das S K, Reese J, Dey S K. Molecular signaling in uterine receptivity for implantation.  Semin Cell Dev Biol. 2000;  11 67-76
• 55 Paria B C, Reese J, Das S K, Dey S K. Deciphering the cross-talk of implantation: advances and challenges.  Science. 2002;  296 2185-2188
• 56 Kurita T, Young P, Brody J R et al.. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis.  Endocrinology. 1998;  139 4708-4713
• 57 Parandoosh Z, Crombie D L, Tetzke T A et al.. Progesterone and oestrogen receptors in the decidualized mouse uterus and effects of different types of anti-progesterone treatment.  J Reprod Fertil. 1995;  105 215-220
• 58 Curtis S W, Clark J, Myers P, Korach K S. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus.  Proc Natl Acad Sci USA. 1999;  96 3646-3651
• 59 Paria B C, Tan J, Lubahn D B, Dey S K, Das S K. Uterine decidual response occurs in estrogen receptor-alpha-deficient mice.  Endocrinology. 1999;  140 2704-2710
• 60 Curtis Hewitt S, Goulding E H, Eddy E M, Korach K S. Studies using the estrogen receptor alpha knockout uterus demonstrate that implantation but not decidualization-associated signaling is estrogen dependent.  Biol Reprod. 2002;  67 1268-1277
• 61 Conneely O M, Mulac-Jericevic B, DeMayo F, Lydon J P, O'Malley B W. Reproductive functions of progesterone receptors.  Recent Prog Horm Res. 2002;  57 339-355
• 62 Das S K, Chakraborty I, Paria B C et al.. Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus.  Mol Endocrinol. 1995;  9 691-705
• 63 Paria B C, Das N, Das S K et al.. Histidine decarboxylase gene in the mouse uterus is regulated by progesterone and correlates with uterine differentiation for blastocyst implantation.  Endocrinology. 1998;  139 3958-3966
• 64 Lim H, Ma L, Ma W G, Maas R L, Dey S K. Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse.  Mol Endocrinol. 1999;  13 1005-1017
• 65 Ma L, Benson G V, Lim H, Dey S K, Maas R L. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES).  Dev Biol. 1998;  197 141-154
• 66 Ding Y Q, Zhu L J, Bagchi M K, Bagchi I C. Progesterone stimulates calcitonin gene expression in the uterus during implantation.  Endocrinology. 1994;  135 2265-2274
• 67 Muffly K E, Jin D F, Okulicz W C, Kilpatrick D L. Gonadal steroids regulate proenkephalin gene expression in a tissue-specific manner within the female reproductive system.  Mol Endocrinol. 1988;  2 979-985
• 68 Chen B, Zhang D, Pollard J W. Progesterone regulation of the mammalian ortholog of methylcitrate dehydratase (immune response gene 1) in the uterine epithelium during implantation through the protein kinase C pathway.  Mol Endocrinol. 2003;  17 2340-2354
• 69 Cheon Y P, Xu X, Bagchi M K, Bagchi I C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse.  Endocrinology. 2003;  144 5623-5630
• 70 Ismail P M, DeMayo F J, Amato P, Lydon J P. Progesterone induction of calcitonin expression in the murine mammary gland.  J Endocrinol. 2004;  180 287-295
• 71 Ingham P W, McMahon A P. Hedgehog signaling in animal development: paradigms and principles.  Genes Dev. 2001;  15 3059-3087
• 72 Takamoto N, Zhao B, Tsai S Y, DeMayo F J. Identification of Indian hedgehog as a progesterone-responsive gene in the murine uterus.  Mol Endocrinol. 2002;  16 2338-2348
• 73 Tsai S Y, Tsai M J. Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age.  Endocr Rev. 1997;  18 229-240
• 74 Matsumoto H, Zhao X, Das S K, Hogan B L, Dey S K. Indian hedgehog as a progesterone-responsive factor mediating epithelial-mesenchymal interactions in the mouse uterus.  Dev Biol. 2002;  245 280-290
• 75 Cheon Y P, Li Q, Xu X et al.. A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation.  Mol Endocrinol. 2002;  16 2853-2871
• 76 Bagchi I C, Cheon Y P, Li Q, Bagchi M K. Progesterone receptor-regulated gene networks in implantation.  Front Biosci. 2003;  8 s852-s861
• 77 Antunes C M, Strolley P D, Rosenshein N B et al.. Endometrial cancer and estrogen use. Report of a large case-control study.  N Engl J Med. 1979;  300 9-13
• 78 Jick H, Watkins R N, Hunter J R et al.. Replacement estrogens and endometrial cancer.  N Engl J Med. 1979;  300 218-222
• 79 Shapiro S, Kaufman D W, Slone D et al.. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium.  N Engl J Med. 1980;  303 485-489
• 80 Herrinton L J, Weiss N S. Postmenopausal unopposed estrogens.  Characteristics of use in relation to the risk of endometrial carcinoma. Ann Epidemiol. 1993;  3 308-318
• 81 Beresford S A, Weiss N S, Voigt L F, McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.  Lancet. 1997;  349 458-461
• 82 Montgomery B E, Daum G S, Dunton C J. Endometrial hyperplasia: a review.  Obstet Gynecol Surv. 2004;  59 368-378
• 83 Arnett-Mansfield R L, DeFazio A, Mote P A, Clarke C L. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.  J Clin Endocrinol Metab. 2004;  89 1429-1442
• 84 Balleine R L, Earls P J, Webster L R et al.. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.  Int J Gynecol Pathol. 2004;  23 138-144
• 85 De Vivo I, Huggins G S, Hankinson S E et al.. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.  Proc Natl Acad Sci USA. 2002;  99 12263-12268
• 86 Cooke P S, Buchanan D L, Young P et al.. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium.  Proc Natl Acad Sci USA. 1997;  94 6535-6540
• 87 Kurita T, Wang Y Z, Donjacour A A et al.. Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system.  Cell Death Differ. 2001;  8 192-200
• 88 Kurita T, Lee K J, Cooke P S, Lydon J P, Cunha G R. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus.  Biol Reprod. 2000;  62 831-838
• 89 McLaughlin M E, Jacks T. Progesterone receptor expression in neurofibromas.  Cancer Res. 2003;  63 752-755
• 90 Brisken C, Park S, Vass T et al.. A paracrine role for the epithelial progesterone receptor in mammary gland development.  Proc Natl Acad Sci USA. 1998;  95 5076-5081
• 91 Edmonds D K, Lindsay K S, Miller J F, Williamson E, Wood P J. Early embryonic mortality in women.  Fertil Steril. 1982;  38 447-453
• 92 Zinaman M J, Clegg E D, Brown C C, O'Connor J, Selevan S G. Estimates of human fertility and pregnancy loss.  Fertil Steril. 1996;  65 503-509
• 93 Ellish N J, Saboda K, O'Connor J et al.. A prospective study of early pregnancy loss.  Hum Reprod. 1996;  11 406-412
• 94 Wilcox A J, Baird D D, Weinberg C R. Time of implantation of the conceptus and loss of pregnancy.  N Engl J Med. 1999;  340 1796-1799
• 95 Society for Assisted Reproductive Technology, American Society for Reproductive Medicine . Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.  Fertil Steril. 2004;  81 1207-1220
• 96 Kao L C, Tulac S, Lobo S et al.. Global gene profiling in human endometrium during the window of implantation.  Endocrinology. 2002;  143 2119-2138
• 97 Writing Group for the Women's Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women.  JAMA. 2002;  288 321-333
• 98 Rossouw J E, Anderson G L, Prentice R L et al.. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.  JAMA. 2002;  288 321-333
• 99 Pike M C, Ross R K. Estrogen-progestin replacement therapy: regulatory action needed.  Breast Cancer Res. 2002;  4 222-223
• 100 Kuller L H. Commentary: hazards of studying women: the oestrogen/progesterone dilemma.  Int J Epidemiol. 2004;  , In press
• 101 Gorins A. Progestins and risk of breast cancer. Much ado about nothing?.  Eur J Gynaecol Oncol. 2003;  24 345-350
• 102 MacLennan A H. The trials and tribulations of long-term postmenopausal hormone therapy.  Obstet Gynecol Surv. 2004;  59 65-67
• 103 McPherson K. Where are we now with hormone replacement therapy? It works for symptoms but is not good for future health.  BMJ. 2004;  328 357-358
• 104 Turgeon J L, McDonnell D P, Martin K A, Wise P M. Hormone therapy: physiological complexity belies therapeutic simplicity.  Science. 2004;  304 1269-1273
• 105 National Cancer Institute Breast Cancer Progress Review Group .Charting the course: priorities for breast cancer research. 1998. Available at: http://prg.nci.nih.gov/breast/finalreport.html. Accessed June 30, 2004
• 106 Pevzner P, Tesler G. Human and mouse genomic sequences reveal extensive breakpoint reuse in mammalian evolution.  Proc Natl Acad Sci USA. 2003;  100 7672-7677
• 107 Cardiff R D, Wagner U, Henninghausen L. Mammary cancer in humans and mice: a tutorial for comparative pathology.  Vet Pathol. 2001;  38 357-358
• 108 Silberstein G B. Postnatal mammary gland morphogenesis.  Microsc Res Tech. 2001;  52 155-162
• 109 Medina D, Sivaraman L, Hilsenbeck S G et al.. Mechanisms of hormonal prevention of breast cancer.  Ann N Y Acad Sci. 2001;  952 23-35
• 110 Sivaraman L, Hilsenbeck S G, Zhong L et al.. Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation.  J Endocrinol. 2001;  171 75-83
• 111 Ginger M R, Gonzalez-Rimbau M F, Gay J P, Rosen J M. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland.  Mol Endocrinol. 2001;  15 1993-2009
• 112 D'Cruz C M, Moody S E, Master S R et al.. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland.  Mol Endocrinol. 2002;  16 2034-2051
• 113 Bocchinfuso W P, Korach K S. Mammary gland development and tumorigenesis in estrogen receptor knockout mice.  J Mammary Gland Biol Neoplasia. 1997;  2 323-334
• 114 Clarke R B, Howell A, Potten C S, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast.  Cancer Res. 1997;  57 4987-4991
• 115 Russo J, Ao X, Grill C, Russo I H. Pattern of distribution of cells positive for estrogen receptor-a and progesterone receptor in relation to proliferating cells in the mammary gland.  Breast Cancer Res Treat. 1999;  53 217-227
• 116 Seagroves T N, Lydon J P, Hovey R C, Vonderhaar B K, Rosen J M. C/EBPβ(CCAAT/Enhancer Binding Protein) controls cell fate determination during mammary gland development.  Mol Endocrinol. 2000;  14 359-368
• 117 Ewan K B, Shyamala G, Ravani S A et al.. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation.  Am J Pathol. 2002;  160 2081-2093
• 118 Shyamala G, Schneider W, Schott D. Developmental regulation of murine mammary progesterone receptor gene expression.  Endocrinology. 1990;  126 2882-2889
• 119 Fantl V, Edwards P A, Steel J H, Vonderhaar B K, Dickson C. Impaired mammary gland development in cyl-1^-/- mice during pregnancy and lactation is epithelial cell autonomous.  Dev Biol. 1999;  212 1-11
• 120 Graham J D, Yeates C, Balleine R L et al.. Characterization of progesterone receptor A and B expression in human breast cancer.  Cancer Res. 1995;  55 5063-5068
• 121 Mote P A, Bartow S, Tran N, Clarke C L. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.  Breast Cancer Res Treat. 2002;  72 163-172
• 122 Fata J E, Kong Y Y, Li J et al.. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.  Cell. 2000;  103 41-50
• 123 Chatterton Jr R T, Lydon J P, Mehta R G et al.. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro.  Cancer Lett. 2002;  188 47-52
• 124 Medina D, Kittrell F S, Shepard A et al.. Hormone dependence in premalignant mammary progression.  Cancer Res. 2003;  63 1067-1072
• 125 Anderson G L, Limacher M, Assaf A R et al.. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.  JAMA. 2004;  291 1701-1712
• 126 Colditz G A, Egan K M, Stampfer M J. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies.  Am J Obstet Gynecol. 1993;  168 1473-1480
• 127 Schairer C, Lubin J, Troisi R et al.. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.  JAMA. 2000;  283 485-491
• 128 Ross R K, Paganini-Hill A, Wan P C, Pike M C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.  J Natl Cancer Inst. 2000;  92 328-332
• 129 Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study.  Lancet. 2003;  362 419-427
• 130 Jull J W. The effects of oestrogens and progesterone on the chemical induction of mammary cancer in mice of the IF strain.  J Path Bact. 1954;  68 547-559
• 131 Robinson S P, Jordan V C. Reversal of antitumor effects of tamoxifen by progesterone in the 7, 12-dimethylbenzanthracene-induced rat mammary carcinoma model.  Cancer Res. 1987;  47 5386-5390
• 132 Russo I H, Russo J. Progestagens and mammary gland development: differentiation versus carcinogenesis.  Acta Endocrinol (Copenh). 1991;  125 7-12
• 133 Aldaz C M, Liao Q Y, La Bate M, Johnston D A. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.  Carcinogenesis. 1996;  17 2069-2072
• 134 Corner G W, Allen W M. Physiology of the corpus luteum II.  Am J Physiol. 1929;  88 326-339
• 135 DeMayo F J, Soyal S, Mukherjee A et al.. A novel progesterone receptor CRE knockin mouse: a powerful in vivo platform to chart cell-fate and to evaluate potential effectors in progesterone receptor specific cell-lineages. Paper presented at the Keystone Symposium on Nuclear Receptor Sisters (6), February 28-March 4 2004 Keystone, CO;